Decreased dopamine D2 receptor binding in essential blepharospasm

被引:23
|
作者
Horie, C. [1 ,2 ]
Suzuki, Y. [1 ,2 ]
Kiyosawa, M. [2 ]
Mochizuki, M. [2 ]
Wakakura, M. [3 ]
Oda, K. [1 ]
Ishiwata, K. [1 ]
Ishii, K. [1 ]
机构
[1] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Itabashi Ku, Tokyo 1730022, Japan
[2] Tokyo Med & Dent Univ, Grad Sch, Dept Ophthalmol & Visual Sci, Tokyo, Japan
[3] Inouye Eye Hosp, Tokyo, Japan
来源
ACTA NEUROLOGICA SCANDINAVICA | 2009年 / 119卷 / 01期
关键词
dopamine D-2 receptor; essential blepharospasm; positron emission tomography; C-11]raclopride; DOPA-RESPONSIVE DYSTONIA; POSITRON-EMISSION-TOMOGRAPHY; BASAL GANGLIA; C-11; RACLOPRIDE; FOCAL DYSTONIA; D2; RECEPTORS; INHIBITION; PET; MUTATION; CARRIERS;
D O I
10.1111/j.1600-0404.2008.01053.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of this study was to investigate whether dopamine D-2 receptor binding was altered in the striatum of essential blepharospasm patients. Striatal dopamine D-2 receptor binding was measured with positron emission tomography and [C-11]raclopride. We studied eight drug-naive patients with bilateral blepharospasm and eight age-matched normal controls. The uptake indices in the blepharospasm group were significantly reduced by 11.7% in the caudate (P < 0.005), 11.6% in the anterior putamen (P < 0.0001), and 10.3% in the posterior putamen (P < 0.005) relative to the control group. This study indicates decreased dopamine D-2 receptor binding in the entire striatal region of blepharospasm patients. The findings suggest that decreased dopamine D-2 receptor binding might be one of the predisposing factors that leads to the dysfunction of the motor circuit, resulting in the loss of broad inhibition of unwanted movements during an intended movement in blepharospasm patients.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 50 条
  • [21] Dopamine D2 receptor gene polymorphisms and clinical response to dopamine D2 receptor antagonists
    Mihara, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S59 - S59
  • [22] Abnormal effective connectivity of dopamine D2 receptor binding in schizophrenia
    Yasuno, F
    Suhara, T
    Okubo, Y
    Ichimiya, T
    Takano, A
    Sudo, Y
    Inoue, M
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2005, 138 (03) : 197 - 207
  • [23] Bivalent Dopamine D2 Receptor Ligands: Synthesis and Binding Properties
    Kuehhorn, Julia
    Huebner, Harald
    Gmeiner, Peter
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (13) : 4896 - 4903
  • [24] Low dopamine D2 receptor binding in subregions of the thalamus in schizophrenia
    Yasuno, F
    Suhara, T
    Okubo, Y
    Sudo, Y
    Inoue, M
    Ichimiya, T
    Takano, A
    Nakayama, K
    Haildin, C
    Farde, L
    AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (06): : 1016 - 1022
  • [25] Potent haloperidol derivatives covalently binding to the dopamine D2 receptor
    Schwalbe, Tobias
    Kaindl, Jonas
    Huebner, Harald
    Gmeiner, Peter
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (19) : 5084 - 5094
  • [26] Altered dopamine D2 receptor binding in atypical facial pain
    Hagelberg, N
    Forssell, H
    Aalto, S
    Rinne, JO
    Scheinin, H
    Taiminen, T
    Någren, K
    Eskola, O
    Jääskeläinen, SK
    PAIN, 2003, 106 (1-2) : 43 - 48
  • [27] Predictions of Binding for Dopamine D2 Receptor Antagonists by the SIE Method
    Wang, Yeng-Tseng
    Su, Zhi-Yuan
    Hsieh, Chang-Huain
    Chen, Cheng-Lung
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009, 49 (10) : 2369 - 2375
  • [28] Low dopamine D2 receptor binding potential in social phobia
    Schneier, FR
    Liebowitz, MR
    Abi-Dargham, A
    Zea-Ponce, Y
    Lin, SH
    Laruelle, M
    AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (03): : 457 - 459
  • [29] Extrastriatal Dopamine D2 Receptor Binding in Huntington's Disease
    Esmaeilzadeh, Mouna
    Farde, Lars
    Karlsson, Per
    Varrone, Andrea
    Halldin, Christer
    Waters, Susanna
    Tedroff, Joakim
    HUMAN BRAIN MAPPING, 2011, 32 (10) : 1626 - 1636
  • [30] Identification of a Zn2+-binding site on the dopamine D2 receptor
    Liu, Y
    Teeter, MM
    DuRand, CJ
    Neve, KA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 339 (03) : 873 - 879